Veradermics, Incorporated (MANE)
NYSE: MANE · Real-Time Price · USD
103.10
+3.00 (3.00%)
At close: Apr 28, 2026, 4:00 PM EDT
102.10
-1.00 (-0.97%)
After-hours: Apr 28, 2026, 4:05 PM EDT
Veradermics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| Selling, General & Admin | 10.28 | 3.5 | 2.35 |
| Research & Development | 62.07 | 23.28 | 14.97 |
| Operating Expenses | 72.35 | 26.78 | 17.32 |
| Operating Income | -72.35 | -26.78 | -17.32 |
| Interest Expense | - | -0.59 | -0.04 |
| Interest & Investment Income | 1.56 | 0.48 | 0.87 |
| Other Non Operating Income (Expenses) | 0.79 | 0.39 | - |
| Pretax Income | -70 | -26.49 | -16.49 |
| Net Income | -70 | -26.49 | -16.49 |
| Preferred Dividends & Other Adjustments | 13.38 | 0.82 | - |
| Net Income to Common | -83.37 | -27.3 | -16.49 |
| Shares Outstanding (Basic) | 1 | 1 | 1 |
| Shares Outstanding (Diluted) | 1 | 1 | 1 |
| Shares Change (YoY) | 1.09% | - | - |
| EPS (Basic) | -111.91 | -37.05 | -22.38 |
| EPS (Diluted) | -111.91 | -37.05 | -22.38 |
| Free Cash Flow | -71.63 | -23.69 | -13.51 |
| Free Cash Flow Per Share | -96.14 | -32.14 | -18.33 |
| EBIT | -72.35 | -26.78 | -17.32 |
Source: S&P Capital IQ. Standard template.
Financial Sources.